Medical College of Georgia officials have tapped Geoffrey I. Holmes, a former pharmaceutical executive, to head its new research oversight committee.
The Office of Clinical Trials Compliance was created earlier this year in the wake of the indictments against former MCG researchers Richard L. Borison and Bruce I. Diamond. The men are accused of funneling more than $10 million in research dollars by diverting the money through their private businesses.
The two men deny any wrongdoing.
The new office - expected to cost about $250,000 annually - is designed to ensure that research at the college meets MCG, state and federal guidelines. Office personnel will track research dollars, monitor patient recruitment for drug studies, and make sure research workers are properly trained.
A Board of Regents audit completed in March found that MCG research procedures were "lacking sound internal control measures."
Before coming to MCG, Mr. Holmes was associate director of research and regulatory services for Premier Research Worldwide in Philadelphia. He retired from Merck Research Laboratories in 1996 after 29 years, retiring as associate director for cardiovascular clinical research.
He has a degree in biology from the University of Pennsylvania and a business degree from the university's Wharton School of Business.